Whitney Zhang
Papers
1
Total Citations
3
H-Index
1
About
Whitney Zhang is a rising surgical oncologist whose work is reshaping our understanding of prostate cancer outcomes. Her primary research focuses on the interplay between surgical technique, tumor pathology, and long-term mortality in robotic radical prostatectomy. In her landmark 2024 study, Zhang challenged a long-held surgical dogma by demonstrating that unifocal positive surgical margins (UPSMs) have no significant impact on prostate cancer-specific mortality, while multifocal PSMs and tumor volume remain critical risk factors. This nuanced finding, drawn from a large international multi-institutional cohort, has already garnered 3 citations and is prompting surgeons to reconsider how they interpret margin status in clinical decision-making. By disentangling the prognostic significance of margin focality from volume, Zhang provides a more precise framework for postoperative risk stratification. Her work not only refines surgical quality metrics but also spares patients unnecessary anxiety over isolated margin positivity. As an emerging voice in urologic oncology, Whitney Zhang is helping to move the field beyond simplistic binary outcomes toward a more sophisticated, evidence-based understanding of what truly drives mortality after prostate cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1